PACIFIC BIOSCIENCES OF CALIFORNIA WKN: A1C3EQ ISIN: US69404D1081 Kürzel: PACB Forum: Aktien Thema: Hauptdiskussion

Pacific Biosciences of California (NASDAQ:PACB): Q3 GAAP EPS of -$0.14 in-line. Revenue of $19.08M (-13.0% Y/Y) misses by $1.25M. Shares -5.66%.

😊👍

"It is an exciting time to join Pacific Biosciences," said Christian Henry. "Our newly launched Sequel IIe instrument will make the use of our long-read technology accessible to more customers than ever before. In addition, HiFi sequencing provides researchers with more complete and accurate sequences, which is one reason why we are engaging in so many important customer collaborations. With the positive customer momentum building around PacBio HiFi sequencing, we expect sequential growth for Q4. Notwithstanding capital sales being impacted in the near term as a result of the COVID-19 pandemic, we continue to be enthusiastic about the long-term growth opportunity for the business."

https://www.pacb.com/smrt-science/smrt-sequencing/

https://www.pacb.com/videos/video-poster-capture-long-read-isoform-sequencing-iso-seq-for-uncovering-human-isoform-diversity-in-the-brain-and-characterizing-sars-cov2-viral-rnas/?platform=hootsuite&utm_campaign=Twitter

Very exciting week for @PacBio in the UK, the first Sequel IIe system has arrived at @OxfordGenomics . The very first time that SMRT Sequencing and #HiFiReads will be available in Oxford. Congratulations to the team at OGC!

We're pleased to be working alongside @PacBio and @ChildrensMercy to use #Azure, AI, and cutting-edge technologies to understand the genetic causes of rare diseases in children:  Children’s Mercy Kansas City Teams Up with Pacific Biosciences to Fight Rare Disease globenewswire.com

Invitae and PacBio https://www.stocktitan.net/news/PACB/invitae-and-pacific-biosciences-collaborate-to-develop-whole-genome-8oatrmo6xx0u.html#

https://finance.yahoo.com/news/pacific-biosciences-unveils-sequel-iie-153003747.html?guccounter=1

https://mobile.twitter.com/PacBio/status/1318902134419619842

Bionano ist aber ein kleiner Fisch.

Die News von heute sind nicht so toll https://www.globenewswire.com/news-release/2020/10/21/2111832/0/en/Bionano-Genomics-Releases-Major-Update-to-Its-Suite-of-Software-Tools-That-Simplifies-Clinical-Analysis-Reduces-Time-to-Actionable-Results-and-Makes-Adoption-by-Clinical-Labs-Easie.html

So bin dabei 😊 hoffe doch, dass ich nicht gleich nachkaufen muss 😅

https://www.openpr.com/news/2043117/long-read-sequencing-market-2020-to-grow-at-a-highest-cagr-of-23-7

News lesen sich gut. Man kann wohl ne kleine Position aufbauen hier, allerdings hab ich echt wenig Lust genau in den ersten Rücksetzter hineinzuinvestieren... 😅

https://www.pressebox.de/inaktiv/forschungsverbund-berlin-ev/Kennst-du-deine-Nachbarn-Fortschritte-in-der-Wildtier-Genomforschung-durch-eine-neue-molekulare-Methode/boxid/1028112